Positive results from Poolbeg Pharma's human challenge trial
Candidate POLB 001 demonstrates potential in treating multiple influenza conditions - News - PharmaTimes
Source: pharmatimes.com
Derek Gilroy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Derek Gilroy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Derek Gilroy Today - Breaking & Trending Today
Investegate |Poolbeg Pharma PLC Announcements | Poolbeg Pharma PLC: Positive Results POLB001 LPS Human Challenge Trial
Investegate announcements from Poolbeg Pharma PLC, Positive Results POLB001 LPS Human Challenge Trial
Source: investegate.co.uk
The end of inflammation? New approach could treat dozens of diseases.
Cancer, ageing, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may...
Source: nationalgeographic.co.uk
The end of inflammation? New approach could treat dozens of diseases.
Cancer, aging, and severe COVID-19 have all been linked to damage from inflammation. Now scientists are flipping their focus to find new drugs that may revolutionize treatments.
Source: nationalgeographic.com
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases Corbus Pharmaceuticals Holdings, Inc. Norwood, Massachusetts, UNITED STATES Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist metabolism program Norwood, MA, Jan. 20, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Compa...
Source: globenewswire.com